Mobile Medical App Whitepaper:
The FDA and European regulators encourage the development of mobile medical apps to enable patients to manage their own health and well-being, yet the regulatory status of a smartphone remains a source of confusion.
The regulatory requirements in the USA and EU- How regulators view Operating System upgrades
- How to maintain validation of medical apps
Novarum DX, has produced a whitepaper available for download which provides guidance on the regulation of mobile medical apps:
Contact Novarum to learn more about the regulation centred around apps with a medical function and how Novarum can support your mHealth strategy via: enquiries@null79.170.44.103